WHC is still in active development. Read this to understand our approach.
depiction of XCGSFFUVFURLIX-UHFFFAOYSA-N.svg
psychonaut

Ergotamine

Check on psychonaut

isomerdesign

Ergotamine

Check on isomerdesign

pubchem

Ergotamine

Check on pubchem

drugmap

Ergotamine

Check on drugmap

wiki

Ergotamine

Check on wiki

Data

InChI: InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)

Synonyms: Ergotamine (INN), Ergotamine (INN),(5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione, Lingraine, Migretamine,379-79-3,Ergotamine dried down 100 microg/mL,(5''alpha)-12''-hydroxy-2''-methyl-5''-(phenylmethyl)ergotoman-3'',6'',18-trione,(5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman,Cafergot,Q419186,Ergostat,GTPL149, Secagyn,Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-, Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1), Ergostat,DB00696, Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt),PR834Q503T,Ergonsvine,(5''alpha)-5''-benzyl-12''-hydroxy-2''-methyl-3'',6'',18-trioxoergotaman,12''-hydroxy-2''-methyl-5''alpha-(phenylmethyl)ergotaman-3'',6'',18-trione, Ergotamine tartrate (VAN), Ergotamina [INN-Spanish],(5alpha,5'beta)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman,ZINC52955754, Lingran,EINECS 204-023-9,113-15-5, Ergotaminum [INN-Latin], Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate, Secupan,SCHEMBL1483,BDBM50027065, Ergotamine [INN:BAN],DTXSID9043774,Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt),1080650-16-3, Wigrettes,NCGC00356592-02, 12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione, Cornutamin, Cornutamine, Ergam,Bellergal, Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-(9CI), Ergonsvine,ERGOTAMINE [MI], Ergotamin,(5'-alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione,CHEBI:64318, Rigetamin,Ergotamine,Ergotamine [INN:BAN],ERGOTAMINE [VANDF],AKOS015896505,Ergotamina [INN-Spanish], Ergotamine tartrate,BRN 0078890,CHEMBL442,ERGOTAMINE [HSDB],Ergodryl,(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide, Ergotartrate,NSC 95090,D07906, Ergomar (TN), ETIN,Ergomar,Ergotamine bitartrate, Ergotamine hemitartrate, (5'A)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman 2,3-dihydroxybutanedioate(2:1),HMS2089H22,Cafertine, Ergotamine, tartrate (2:1) (salt) (8CI),Gynergen,ergotaminum,UNII-PR834Q503T, Ergomar, Ergoton-A,Ergotamin,HSDB 4076,ERM, Neo-ergotin,N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-methyl-[?]carboxamide,ERGOTAMINE [WHO-DD],12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione,Ergotamina,ergotamine tartrate, Gotamine tartrate, Medihaler ergotamine,Rigetamin, ERGOTAMINE (SEE ALSO: ERGOTAMINE TARTRATE (CAS 379-79-3)), Femergin,AB01275473-01, Exmigra,Avetol, Ergotamine, tartrate (2:1), Ergate,NSC-95090,ERGOTAMINE [INN],Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate,DHE,Ergotaminum [INN-Latin], Ergotamine bitartrate,Migergot, Temigran,ERGOTAMINE


Estimated data

Solubility: -4.541 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 8.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.